Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Plum, J.
Right arrow Articles by Grabensee, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plum, J.
Right arrow Articles by Grabensee, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 12, Issue 8 1652-1660, Copyright © 1997 by Oxford University Press


ORIGINAL ARTICLES

In vivo and in vivo effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations

J Plum, A Fussholler, G Schoenicke, T Busch, C Erren, C Fieseler, J Kirchgessner, J Passlick-Deetjen and B Grabensee
Department of Nephrology and Rheumatology, Heinrich-Heine University Duesseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany; Corresponding author

Background: Increasing evidence suggests that conventional PD solutions are detrimental to host defence mechanisms of peritoneal cells. We tested a new amino-acid-based and bicarbonate-buffered PD solution under in vivo and in vitro conditions. Method: During a prospective cross-over randomized intraindividual study 10 CAPD patients were investigated with three different solutions: Amino/Bic, 1% amino acid, 34 mmol/l bicarbonate; Glu/Bic, 1.5% glucose, 34 mmol/l bicarbonate; and Glu/Lac, 1.5% glucose, 35 mmol/l lactate. A PET was performed and transport properties (clearance, D/P ratio, MTAC) were calculated. Prostanoid and cytokine concentrations were measured in serum and the 6 h effluent. Using an in vitro model, mononuclear leukocytes of healthy donors were also incubated with the test fluid. In vivo results. Peritoneal clearance and MTAC of small solutes (creatinine, urea) were not significantly altered by amino acids or bicarbonate. Peritoneal permeability and transperitoneal excretion of higher-weight protein molecules ({beta}2-microglobulin, albumin, IgG) were increased with Amino/Bic compared to Glu/Lac (P<0.05) (D/P ratio albumin: Amino/Bic, 0.027±0.003; Glu/Bic, 0.023±0.003; Glu/Lac, 0.022±0.002). Application of Amino/Bic was accompanied by an increased effluent concentration of Il-6, Il-8, TNF&agr; PGE2, and 6-keto-PGR1a (P<0.05). Dialysate nitrite/nitrate and cGMP concentrations (as indicators of NO generation) did not differ between the solutions. In vitro results. Both bicarbonate fluids demonstrated a better preservation of the mitochondrial dehydrogenases activity (MTT assay) compared to Glu/Lac (P <0.01) (Amino/Bic: 80.6±3.2%; Glu/Bic: 86.0±1.8%; Glu/Lac, 64.9±2.3%, referred to RPMI as control). Constitutive and LPS stimulated release of Il-1{beta} and Il-6 was less suppressed with both bicarbonate fluids (P<0.05) LPS-stim. Il-6 release: Amino.Bic, 33.0±6.6%; Glu/Bic, 65.5±10.3%; Glu/Lac, 1.5±0.7% referred to RPMI). Conclusion: Application of an amino-acid/bicarbonate solution resulted in a small but significant increase in peritoneal permeability. Also increased concentrations of various cytokines/prostanoids were measured in the effluent. According to in vitro testing with mononuclear phagocytes both bicarbonate-buffered fluids were to the same extent less inhibitory to certain cell functions than lactate-buffered solution. Keywords: peritoneal dialysis fluids; peritoneal transport; bicarbonate; lactate; cytokines; prostanoids
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
pdiHome page
H. L. Tjiong, R. Swart, J. W. van den Berg, and M. W. Fieren
AMINO ACID-BASED PERITONEAL DIALYSIS SOLUTIONS FOR MALNUTRITION: NEW PERSPECTIVES
Perit. Dial. Int., July 1, 2009; 29(4): 384 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. J. Margetts and D. N. Churchill
Acquired Ultrafiltration Dysfunction in Peritoneal Dialysis Patients
J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2787 - 2794.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.